Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock

doi:10.1084/jem.173.6.1305

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Gadina, M.
	Articles by Ghezzi, P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Gadina, M.
	Articles by Ghezzi, P.


Social Bookmarking

	What's this?

ARTICLES

Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock

M Gadina, R Bertini, M Mengozzi, M Zandalasini, A Mantovani and P Ghezzi
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

The present study was designed to define the potential of chlorpromazine (CPZ) as a protective agent against lipopolysaccharide (LPS) toxicity in comparison with glucocorticoids, and to obtain initial correlations with its effects on the levels of tumor necrosis factor (TNF), a pivotal mediator of endotoxic shock. It was found that CPZ protects mice, normal or adrenalectomized, and guinea pigs against lethality of LPS, and inhibited TNF serum levels, like dexamethasone (DEX), a well-known inhibitor of TNF synthesis. CPZ protected against LPS lethality when administered 30 minutes (min) before, simultaneously, or up to 10 min after LPS and was ineffective when given 30 min after LPS, paralleling the inhibitory effect on TNF production. In another experimental model, where mice were sensitized to LPS toxicity by actinomycin D, CPZ significantly inhibited LPS lethality and hepatotoxicity, whereas under these conditions DEX was inactive. These experiments indicate that CPZ has a protective action in both glucocorticoid-sensitive and -resistant models of endotoxic shock.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Buchweitz, J. P., Ganey, P. E., Bursian, S. J., Roth, R. A. (2002). Underlying Endotoxemia Augments Toxic Responses to Chlorpromazine: Is There a Relationship to Drug Idiosyncrasy?. J. Pharmacol. Exp. Ther. 300: 460-467 [Abstract] [Full Text]
MIGNON, A., ROUQUET, N., FABRE, M., MARTIN, S., PAGES, J.�C., DHAINAUT, J.�F., KAHN, A., BRIAND, P., JOULIN, V. (1999). LPS Challenge in D-galactosamine-Sensitized Mice Accounts for Caspase-dependent Fulminant Hepatitis, not for Septic Shock. Am. J. Respir. Crit. Care Med. 159: 1308-1315 [Abstract] [Full Text]
Demitri, M.T., Velucchi, M., Bracci, L., Rustici, A., Porro, M., Villa, P., Ghezzi, P. (1996). Inhibition of LPS-induced systemic and local TNF production by a synthetic anti-endotoxin peptide (SAEP-2). Innate Immunity 3: 445-454 [Abstract]
Kotanidou, A., Choi, A. M.�K., Winchurch, R. A., Otterbein, L., Fessler, H. E. (1996). Urethan anesthesia protects rats against lethal endotoxemia and reduces TNF-alpha release. J. Appl. Physiol. 81: 2304-2311 [Abstract] [Full Text]
Novogrodsky, A, Vanichkin, A, Patya, M, Gazit, A, Osherov, N, Levitzki, A (1994). Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264: 1319-1322 [Abstract]